Information was received from multiple sources (manufacturer representative, healthcare provider) regarding a patient who was receiving intrathecal bupivacaine 40 mg/ml at an unknown dose, morphing 20 mg/ml at 11.992 mg/day, and baclofen 500 mcg/ml at an unknown dose via an implantable pump for unknown indications for use.It was reported that the pump was replaced on (b)(6) 2022 and doctor opened the pocket and found the pump and pocket coated with a gray-white flaky crystalline material.There were no known environmental, external, patient factors that may have led or contributed to the issue.The material was sent to pathology.The issue was resolved at the time of this report and the patient's status was "alive- no injury".The patient's weight was asked but unknown and medical history included chronic pain.Additional information was received from a healthcare provider (hcp) via a company representative (rep) on (b)(6) 2022 indicated the reason for the pump replacement was normal battery depletion.The cause of the crystalline material has not been determined by pathology at this time.
|